Research Sample bioBank

Find a Research Sample:

Browse Alphabetically

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

NASH Clinical Research Samples

Discovery Life Sciences provides the highest quality NASH Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All NASH Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 61 of 61 total samples
 (0)
Checkout
Advanced Data View:
Showing 61 of 61 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Test 2Test Data 2Sample Detail 2Test 3Test Data 3Sample Detail 3Product
Details
Price
Buy
Additional Information 1Additional Data 1Additional Detail 1Additional Information 2Additional Data 2Additional Detail 2Additional Information 3Additional Data 3Additional Detail 3Additional Information 4Additional Data 4Additional Detail 4Additional Information 5Additional Data 5Additional Information 6Additional Data 6Additional Information 7Additional Data 7Additional Detail 7ICD10 codes
DLS16-67178-SNASHUSASerum1.001.00$150.0073 YFWhite<-70C14-Sep-16Clinical DiagnosisNASHChest X-rayNo acute cardiopulmonary process17-Aug-16Kidney ultrasoundNormal17-Aug-16$150.00Initial Date of Disease Diagnosis17-Aug-2016Ever Developed JaundiceNoLiver BiopsyNoCirrhosisYes2013 (Liver panel labs)ComorbiditiesNoneCurrent Prescription MedicationsAcetaminophen, Ascorbic acid, Ciprofloxacin, Insulin glargine, Insulin lispro, Lactulose, Magnesium gluconate, Omeprazole, Propranolol, Tramadol, TrazodoneAbbott ArchitectAlbumin: 3.4 g/dL ALP: 94 U/L ALT: <6 U/L AST: 24 U/L GGT: 38 U/L LD: 185 U/L Protein: 5.2 g/dL13-Mar-2018
DLS16-67184-K2NASHUSAK2 EDTA Plasma0.901.00$150.0057 YMBlack<-70C09-Sep-16Clinical DiagnosisNASHAbdomen ultrasoundHepatocellular disease Steatosis12-Feb-16$150.00Initial Date of Disease Diagnosis26-Feb-2014Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsAmlodipine, Clindamycin, Diclofenac / Misoprostol, Fluticasone, Hydrocodone / Acetaminophen, Hydrocortisone, Omeprazole, Sildenafil
DLS16-82843-K2NASHUSAK2 EDTA Plasma1.001.00$150.0056 YFHispanic<-70C01-Feb-17Clinical DiagnosisNASHUltrasoundIncreased echogenicity30-Nov-16$150.00Initial Date of Disease Diagnosis30-Dec-2016Ever Developed JaundiceNoLiver BiopsyYes30-Dec-2016 (Fibrosis 3-4, NAS 5+)CirrhosisNoComorbiditiesRelapsing polychondritis, OsteoporosisCurrent Prescription MedicationFosamax, Colchicine, Gabapentin, Probiotic, Vitamin B complex, Vitamin D, Calcium, Fish oil
DLS16-82844-K2NASHUSAK2 EDTA Plasma1.007.00$150.0057 YFWhite<-70C15-Feb-17Clinical DiagnosisNASHN/AN/AN/ACTLow attenuation diffusely throughout liver suggestive of stenosis25-Apr-14$150.00Initial Date of Disease Diagnosis18-Jun-2014Ever Developed JaundiceNoLiver BiopsyYesFibrosis 2, NAS 5+, 18-Jun-2014 CirrhosisNoComorbiditiesMalignant neoplasm of tongue, Diabetes mellitus, Coronary artery disease, Obstructive sleep apnea, Arthritis, GERDCurrent Prescription MedicationsOmeprazole, Metformin, Flexeril, Januvia, Crestor
DLS16-82853-K2NASHUSAK2 EDTA Plasma1.005.00$150.0055 YFWhite<-70C10-May-17Clinical DiagnosisNASHN/AN/AN/ACTSteatosis9-Feb-17$150.00Initial Date of Disease Diagnosis2-May-17Ever Developed JaundiceNoLiver BiopsyYesFibrosis 1, NAS 5+, 2-May-2017CirrhosisNoComorbiditiesAsthma, Diabetes, Melanoma, Lung cancer, Neuroendocrine tumor, Arthritis, Appendectomy, Cholecystectomy, Adrenal gland tumors, GERDCurrent Prescription MedicationsJanuvia, Protonix, Lomotil, Lopressor, Furosemide, Mirapex, Celecoxib, Lyrica, Trazodone, Vytorin fenofibrate, Metformin, Fetzima, Proair, Symbicort, Albuterol, Oxygen, Questran
DLS16-87695-K2NASHUSAK2 EDTA Plasma1.001.00$150.0048 YMWhite<-70C14-Apr-17Clinical DiagnosisNASHN/AN/AN/AN/AN/AN/A$150.00Initial Date of Disease Diagnosis5-Apr-2017Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesObesity, HypercholesterolemiaCurrent Prescription MedicationsAmlodipine, Atorvastatin, Metoprolol succinate, Olmesartan-hydrochlorthiazide
DLS16-87699-SNASHUSASerum1.001.00$150.0050 YMWhite<-70C08-Mar-17Clinical DiagnosisNASHUltrasoundAppearance of liver could relate to steatosis and / or hepatocellular disease28-Feb-17N/AN/AN/A$150.00Initial Date of Disease Diagnosis27-Feb-2017Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesGERD, DVT, Anxiety and depression, Pulmonary embolism, Vitamin D deficiencyCurrent Prescription MedicationsAlprazolam, Aspirin, Hydrocodone-acetaminophen, Ranitidine, Meloxicam, Atenolol, Amitriptyline
DLS16-87718-SNASHUSASerum1.001.00$150.0055 YMAsian<-70C28-Feb-17Clinical DiagnosisNASHN/AN/AN/AN/AN/AN/A$150.00Initial Date of Disease Diagnosis1997Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesSjogren's syndrome, Glaucoma suspect, Hypertriglyceridemia, Irregular heartbeatCurrent Prescription MedicationsLamisil
DLS16-87725-K2NASHUSAK2 EDTA Plasma1.002.00$150.0033 YMWhite<-70C12-Apr-17Clinical DiagnosisNASHUltrasound AbdomenFatty liver. Diffuse increased echogenicity of hepatic parenchyma secondary to hepatic steatosis.3-Feb-17Chest X-rayNo acute cardiopulmonary process25-Jun-14$150.00Initial Date of Disease Diagnosis28-Mar-2017Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesADD, Depression, DyshydrosisCurrent Prescription MedicationsAlprazolam, Betamethasone, Clobetasol, Synthroid, Multivitamin, Concentra
DLS16-87731-K2NASHUSAK2 EDTA Plasma1.004.00$150.0076 YFWhite<-70C06-Mar-17Clinical DiagnosisNASHN/AN/AN/AN/AN/AN/A$150.00Initial Date of Disease Diagnosis2013Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesGERD, Right shoulder pain, Ischemic colitis, DiverticulosisCurrent Prescription MedicationsAlbuterol, Amitriptyline, Betamethasone dipropionate, Bifidobacterium infantis, Cephalexin, Cholecalciferol, Sulfamethoxazole, Levothyroxine, Milk thistle, Omeprazole, Triamcinolone
DLS16-87739-K2NASHUSAK2 EDTA Plasma1.003.00$150.0038 YMMiddle Eastern<-70C24-Feb-17Clinical DiagnosisNASHUltrasound AbdomenIncreased hepatic echogenicity suggests diffuse hepatocellular disease, cirrhosis / steatosis.22-Jun-16N/AN/AN/A$150.00Initial Date of Disease Diagnosis2011Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesHypertriglyceridemia, Cervical spine disease, Chronic rhinitis, Severe persistent asthma, Hordeolum externum of left upper eyelidCurrent Prescription MedicationsAlprazolam, Ciprofloxacin, Fluoxetine, Nexium, Hydrocodone - acetaminophen, Ibuprofen
DLS16-87701-K2NASHUSAK2 EDTA Plasma1.002.00$150.0054 YMArab<-70C17-Mar-17Clinical DiagnosisNASHChest X-raySmall bilateral effusions and asymmetric airspace opacity right upper lung which could be edema / pneumonia.14-May-17Ultrasound AbdomenLiver cirrhosis. Cholelithiasis and sludge within gallbladder. Scattered moderate ascites.3-May-17$150.00Initial Date of Disease Diagnosis2015Ever Developed JaundiceNoLiver BiopsyNoCirrhosis?YesCT AbdoMen and Pelvis 26-Apr-2017ComorbiditiesEsophageal varices, HyperlipideMia / Elevated lipase, Acute blood loss aneMia, Portal vein throMbosis, AbnorMal urinanalysisCurrent Prescription medicationsCholestyraMine, ClotriMazole-BetaMethasone, Enoxaparin, ErgocalciFerol, Folic acid, FuroseMide, Hydrocortisone, Lactulose, Pantoprazole, Senna, SpironolactoneAll Known Test Results Performed in Previous Six monthsALT: 46 U/L, AST: 69 U/L, Bilirubin (direct): 4.6 Mg/dL, Bilirubin (total): 15.2 Mg/dL, 16-17-May-2017, Cholesterol: 155 Mg/dL, Triglycerides: 94 Mg/dL, HDL: 46 Mg/dL, LDL: 90 Mg/dL 6-Jan-2017
DLS16-87723-K2NASHUSAK2 EDTA Plasma1.002.00$150.0048 YFWhite<-70C18-Aug-17Clinical DiagnosisNASHN/AN/AN/A$150.00Initial Date of Disease Diagnosis2016Ever Developed JaundiceNoLiver BiopsyNoCirrhosis?NoComorbiditiesAbdoMinal painCurrent Prescription medicationsPropranololAll Known Test Results Performed in Previous Six monthsALT: 24 U/L, AST: 37 U/LBilirubin (total): 0.4 Mg/dL 14-Aug-2017
DLS16-87730-K2NASHUSAK2 EDTA Plasma1.004.00$150.0070 YMWhite<-70C10-Aug-17Clinical DiagnosisNASHUltrasound Liver Small amount of ascites.19-Aug-17$150.00Initial Date of Disease Diagnosis2005Ever Developed JaundiceNoLiver BiopsyYesNo signicant fibrosis. 21-feb-2017Cirrhosis?NoComorbiditiesS/P liver transplant, IMMunosuppression, Diabetes Mellitus, Sacral decubitus ulcerCurrent Prescription medicationsAlbuterol, Aspirin, Ascorbic acid, CholecalciFerol, ClotriMazole, FuroseMide, Gabapentin, IpratropiuM, Levothyroxine, MagnesiuM oxide, Metoprolol tartrate, TacroliMus, Ursodiol, TaMsulosinAll Known Test Results Performed in Previous Six monthsALT: 16 U/L, AST: 17 U/L Bilirubin (direct): 0.1 Mg/dL, Bilirubin (total): 0.5 Mg/dL, Cholesterol: 117 Mg/dL 10-Aug-2017
DLS16-87733-K2NASHUSAK2 EDTA Plasma0.501.00$150.0021 YFHispanic<-70C22-May-17Clinical DiagnosisNASHUltrasound PelvisNormal uterus31-Aug-15$150.00Initial Date of Disease DiagnosisMay-17Ever Developed JaundiceNoLiver BiopsyNoCirrhosis?NoComorbiditiesObesity, Elevated enzyMeCurrent Prescription medicationsNoneAll Known Test Results Performed in Previous Six monthsALT: 52 U/L Bilirubin (total): 0.5 Mg/dL 27-Mar-2017
DLS16-87740-K2NASHUSAK2 EDTA Plasma1.003.00$150.0056 YMWhite<-70C08-Sep-17Clinical DiagnosisNASHUltrasound Abdomen Increased hepatic echogenicity suggests diffuse hepatocellular disease, such as steatosis.4-Aug-15CT LiverHepatic steatosis. fat containing umbilical hernia.15-Sep-16$150.00Initial Date of Disease Diagnosis2013Ever Developed JaundiceNoLiver BiopsyNoCirrhosis?NoComorbiditiesAsthMa, GERD, Sleep apnea, PriMary insoMnia, Obesity class II, Chronic headachesCurrent Prescription medicationsAlbuterol, Azelastine, Carisprodol, MetForMin, MoMetasone, OMeprazole, Ondansetron, Propranolol, Sertaline, SildenaFil, SiMvastatin, ZolpideMAll Known Test Results Performed in Previous Six monthsALT: 56 U/L, AST: 29 U/L Bilirubin (total): 0.4 Mg/dL Cholesterol: 141 Mg/dL, Triglycerides: 159 Mg/dL, HDL: 33 Mg/dL, LDL: 76 Mg/dL 16-Aug-2016
DLS16-87741-K2NASHUSAK2 EDTA Plasma1.003.00$150.0064 YMWhite<-70C12-Jun-17Clinical DiagnosisNASHCT Abdomen and Pelvis S/P liver transplant with moderate ascites and anasarca. Persistent splenomegaly, esophageal and splenic varices.2-Jun-17mRI BrainNo obvious acute intracranial abnormality.3-Jun-17$150.00Initial Date of Disease Diagnosis2009Ever Developed JaundiceNoLiver BiopsyYesTransplant liver minimal steatosis and minimal portal inflammation. No significant fibrosis detected. 21-may-2017Cirrhosis?YesCT Liver 14-Apr-2017ComorbiditiesChronic liver Failure without hepatic coMa, Portal vein throMbosis, Encephalopathy, Acid-base disorder, Chonic hyponatreMiaCurrent Prescription medicationsAMoxicillin, Aspirin, ClotriMazole, Cyclosporine, FuroseMide, Insulin NPH, OMeprazole, Prednisolone, TraMadol, Valganciclovir, WarFarin, MoFetilAll Known Test Results Performed in Previous Six monthsALT: 21 U/L, AST: 18 U/L Bilirubin (direct): 0.5 Mg/dL, Bilirubin (total): 0.1 Mg/dL, Cholesterol: 119 Mg/dL 22-Jun-2017
DLS16-87742-K2NASHUSAK2 EDTA Plasma1.003.00$150.0067 YMWhite<-70C31-Aug-17Clinical DiagnosisNASHCT AbdomenCirrhosis morphology of the liver. mild splenomegaly. Ascites.8-Apr-17mRI BrainNo intracranial pathology.6-Jul-17$150.00Initial Date of Disease Diagnosis2010Ever Developed JaundiceNoLiver BiopsyYesCirrhosis with mild activity. 4-Apr-2017 Cirrhosis?YesLiver Biopsy 4-Apr-2017ComorbiditiesHepatic coMa, Ascites, Elevated CPK, Transient neurological syMptoMs.Current Prescription medicationsB coMplex, Doxycycline, FuroseMide, Lisinopril, OMeprazole, Prednisolone, Spironolactone, VitaMin E, MultivitaMin, RiFaxiMinAll Known Test Results Performed in Previous Six monthsALT: 100 U/L, AST: 91 U/L Bilirubin (direct): 1.4 Mg/dL, 31-Aug-2017, Cholesterol: 135 Mg/dL, Triglycerides: 44 Mg/dL, HDL: 46 Mg/dL, LDL: 80 Mg/dL 8-Jul-2017
DLS16-82809-K2NASHUSAK2 EDTA Plasma1.009.00$150.0056 YMHispanic<-70C01-Sep-17Clinical DiagnosisNASHUltrasoundNodular appearing liver which may occur with cirrhosis22-Sep-15$150.00Initial Date of Disease Diagnosis6-Aug-2014Ever Developed JaundiceNoLiver BiopsyYes | 6-Aug-14Mild steatosis; Mild steatohepatitis bridging fibrosis with evolving cirrhosis Stage 3-4CirrhosisYes | 22-Sep-15UltrasoundComorbiditiesHypertension, Thyroid disease, High cholesterol, DiabetesCurrent Prescription MedicationsLipitor, Metformin, Levothyroxine, DiovanAll Known Test Results Performed in Previous Six MonthsALT: 38 U/L; AST: 71 U/L; Bilirubin (total): 2.2 mg/dL; 24-Aug-2017
DLS16-82818-K2NASHUSAK2 EDTA Plasma1.005.00$150.0056 YMWhite<-70C31-Jul-17Clinical DiagnosisNASHCTMarked fatty change in liver14-Sep-11$150.00Initial Date of Disease Diagnosis10-Feb-2015Ever Developed JaundiceNoLiver BiopsyYes | 10-Feb-15Fibrosis, NAS 4CirrhosisNoComorbiditiesGERD, NephrolithiasisCurrent Prescription MedicationsLovaza, Atorvastatin, Theralith XR, Fluticasone propionate, ZyrtecAll Known Test Results Performed in Previous Six MonthsALT: 45 U/L; AST: 32 U/L; Bilirubin (direct): 0.13 mg/dL; Bilirubin (total): 0.6 mg/dL; 31-Jul-2017
DLS16-82821-K2NASHUSAK2 EDTA Plasma1.008.00$150.0051 YFWhite<-70C17-Aug-17Clinical DiagnosisNASHUltrasoundLiver normal size. Echogenicity w/o evidence of any focal masses14-May-08$150.00Initial Date of Disease Diagnosis27-Mar-2008Ever Developed JaundiceNoLiver BiopsyYes | 27-Mar-08Steatohepatitis, Stage I FibrosisCirrhosisNoComorbiditiesDiabetes, High cholesterol, HypothyroidismCurrent Prescription MedicationsSynthroid, Lisinopril, Hydrochlorothiazide, Levothyroxine sodium, Glimepiride, Toujeo SoloStarAll Known Test Results Performed in Previous Six MonthsALT: 62 U/L; AST: 103 U/L; Bilirubin (total): 0.5 mg/dL; Cholesterol: 212 mg/dL; Triglycerides: 182 mg/dL; HDL: 39 mg/dL; LDL: 137 mg/dL 26-Jul-2017
DLS16-82852-K2NASHUSAK2 EDTA Plasma1.003.00$150.0048 YMWhite<-70C12-Sep-17Clinical DiagnosisNASHUltrasoundHepatomegaly with fatty infiltration of liver16-Jul-17$150.00Initial Date of Disease Diagnosis17-Aug-2017Ever Developed JaundiceNoLiver BiopsyYes | 17-Aug-17Stage 2 Fibrosis, NASHCirrhosisNoComorbiditiesGout, Hyperuricemia, Psoriatic arthritisCurrent Prescription MedicationsNoneAll Known Test Results Performed in Previous Six MonthsALT: 250 U/L; AST: 226 U/L; Bilirubin (direct): <0.1 mg/dL; Bilirubin (total): 1.2 mg/dL 31-Jul-2017;
DLS16-82816-SNASHUSASerum1.001.00$150.0060 YFWhite<-70C10-Jul-17Clinical DiagnosisNASHUltrasoundFatty infiltration28-Aug-12X-RayNo acute process found17-May-10$150.00Initial Date of Disease Diagnosis13-Nov-2013Ever Developed JaundiceNoLiver BiopsyYes | 28-Jul-15Fibrosis 1, NAS 4CirrhosisNoComorbiditiesUlcerative collitis, GallstonesCurrent Prescription MedicationsRemicade, Zetia, SimvastatinAll Known Test Results Performed in Previous Six MonthsBilirubin (total): 0.7 mg/dL; 4-Apr-2017
KH18-04325NASHUSAK2 EDTA Plasma0.401.00$75.0026 YFU/A<-70C19-Jan-18Abbott Architect170 U/LALTAbbott Architect118 U/LAST$75.00K75.81
KH18-04327NASHUSAK2 EDTA Plasma0.301.00$75.0026 YFWhite<-70C23-Jan-18Abbott Architect147 U/LALTAbbott Architect102 U/LAST$75.00K75.81
KH18-10307NASHUSASerum1.501.00$75.0078 YMWhite<-70C01-Feb-18Abbott Architect208 U/LASTAbbott Architect167 U/LALT$75.00K75.81
KH18-11776NASHUSAK2 EDTA Plasma0.251.00$75.0065 YFWhite<-70C27-Feb-18Abbott Architect14 U/LALTAbbott Architect16 U/LAST$75.00BMI39.26Height | Weight67 | 100K75.81
KH18-10743NASHUSASerum1.251.00$75.0057 YMBlack<-70C27-Feb-18Abbott Architect101 U/LALTAbbott Architect73 U/LAST$75.00K75.81
DLS16-13605-K2NASHCanadaK2 EDTA Plasma1.004.00$150.0057 YMAsian<-70C21-Feb-18Clinical DiagnosisNASHUltrasoundFatty infiltration15-Feb-18$150.00Initial Date of Disease DiagnosisUnk-2007Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesHypertension; Dyslipidemia; History of prostate cancer; Glucose toleranceCurrent Prescription MedicationsLipitor; RamiprilAll Known Test Results Performed in Previous Six monthsALT: 61 U/L | AST: 37 U/L | GGT: 86 U/L | Bilirubin (direct): 4 umol/L | Bilirubin (total): 12 umol/L 10-Feb-2018
KH18-12945NASHUSASerum1.251.00$75.0073 YMBlack<-70C14-Mar-18Abbott Architect24 U/LALTAbbott Architect38 U/LAST$75.00K75.81
KH18-14401NASHUSASerum1.001.00$75.0028 YMWhite<-70C06-Mar-18Abbott Architect17 U/LASTAbbott Architect19 U/LALT$75.00K75.81
KH18-16327NASHUSAK2 EDTA Plasma0.401.00$75.0018 YFBlack<-70C03-Apr-18Abbott Architect9 U/LALTAbbott Architect12 U/LAST$75.00K75.81
KH18-15615NASHUSASerum1.251.00$75.0050 YFWhite<-70C03-Apr-18Abbott Architect16 U/LASTAbbott Architect25 U/LALT$75.00K75.81
KH18-15616NASHUSASerum1.001.00$75.0071 YMWhite<-70C21-Mar-18Abbott Architect22 U/LASTAbbott Architect29 U/LALT$75.00K75.81
KH18-15617NASHUSASerum1.751.00$75.0018 YFBlack<-70C03-Apr-18Abbott Architect12 U/LASTAbbott Architect9 U/LALT$75.00K75.81
KH18-15815NASHUSASerum1.001.00$75.0015 YMWhite<-70C19-Mar-18Abbott Architect62 U/LASTAbbott Architect130 U/LALT$75.00K75.81
KH18-16878NASHUSAK2 EDTA Plasma0.601.00$75.0065 YFWhite<-70C15-Apr-18Abbott Architect21 U/LALTAbbott Architect22 U/LAST$75.00K75.81
KH18-19346NASHUSASerum1.001.00$75.0078 YMWhite<-70C29-Apr-18Abbott Architect55 U/LASTAbbott Architect13 U/LALT$75.00K75.81
KH18-19347NASHUSASerum1.001.00$75.0072 YFU/A<-70C05-Apr-18Abbott Architect28 U/LASTAbbott Architect10 U/LALT$75.00K75.81
KH18-19348NASHUSASerum1.001.00$75.0073 YFWhite<-70C23-Apr-18Abbott Architect18 U/LASTAbbott Architect15 U/LALT$75.00K75.81
KH18-19548NASHUSASerum1.251.00$75.0078 YMWhite<-70C16-Apr-18Abbott Architect43 U/LASTAbbott Architect30 U/LALT$75.00K75.81
KH18-21661NASHUSAK2 EDTA Plasma0.751.00$75.0078 YMWhite<-70C11-May-18Abbott Architect50 U/LASTAbbott Architect8 U/L ALT$75.00K75.81
DLS16-13614-K2NASHCanadaK2 EDTA Plasma1.007.00$150.0063 YFAmerican Indian<-70C03-May-18Clinical DiagnosisNASH$150.00Initial Date of Disease Diagnosis01-Apr-14Ever Developed JaundiceNoLiver BiopsyYes | NAS Score: Steatosis - 1; Lobular inflammation-1; HEP Ballooning - 2; Stage 323-Jun-17CirrhosisNoComorbiditiesNoneCurrent Prescription MedicationsNoneAll Known Test Results Performed in Previous Six monthsALT: 34 U/L | AST: 45 U/L | GGT: 44 U/L | Bilirubin (direct): 2 umol/L | Bilirubin (total): 9 umol/L | 3-May-2018
DLS16-13613-K2NASHCanadaK2 EDTA Plasma1.007.00$150.0059 YMWhite<-70C02-May-18Clinical DiagnosisNASH$150.00Initial Date of Disease Diagnosis04-Sep-07Ever Developed JaundiceNoLiver BiopsyYes | Grade 2; Stage 4 Moderate macrovesicular steatosis.04-Sep-07CirrhosisYesComorbiditiesHypertension; Dyslipidemia; Arthritis; Diabetes, Type 2Current Prescription MedicationsTradjenta; Altace; Metformin; Crestor; Insulin; NaproxenAll Known Test Results Performed in Previous Six monthsALT: 52 U/L | AST: 41 U/L | GGT: 70 U/L | Bilirubin (direct): 3 umol/L | Bilirubin (total): 9 umol/L | 27-Apr-2018
KH18-24584NASHUSASerum1.251.00$75.0073 YFWhite<-70C02-Jun-18Abbott Architect17 U/LALTAbbott Architect16 U/LAST$75.00K75.81
DLS17-038152-K2NASHUSAK2 EDTA Plasma1.005.00$150.0061 YFWhite<-70C02-Mar-18Clincal DiagnosisNASHUltrasoundHepatic fatty infiltration.23-Feb-16$150.00Initial Date of Disease Diagnosis23-Feb-2016Ever Developed JaundiceNoLiver BiopsyNoCirrhosisNoComorbiditiesHypertension, High cholesterol, Diabetes, ArthritisCurrent Prescription MedicationsLovastatin, Montelukast sodium, Lisinopril, Metformin, ViibrydAll Known Test Results Performed in Previous Six monthsALT: 75 U/L | AST: 46 U/L 30-Jan-2018
DLS17-038145-K2NASHUSAK2 EDTA Plasma1.007.00$150.0054 YFWhite<-70C23-May-18Clincal DiagnosisNASHUltrasoundCholelithiasis fatty liver.21-Jul-16CTDiffuse low attenuation consistent with fatty liver.17-May-18$150.00Initial Date of Disease Diagnosis19-Aug-2015Ever Developed JaundiceNoLiver BiopsyYes | 19-Aug-2015 Moderate macrovascular steatosis and mild portal fibrosisCirrhosisNoComorbiditiesDiabetes, Hypertension, Chronic pain disorder, Arthritis, Thyroid disease, GERD, DJD, Arthralgia, BursitisCurrent Prescription MedicationsJanumet, Gabapentin, Metoprolol tartrate, Prednisone, Morphine sulfate, Niacin, Atorvastatin calcium, Invokana, Pantoprazole, Levothyroxine sodium, Humalog, Cyclobenzaprine HCLAll Known Test Results Performed in Previous Six monthsALT: 27 U/L | AST: 23 U/L | Bilirubin (total): 0.5 mg/dL 11-May-18
KH18-28416NASHUSASerum1.501.00$75.0033 YFWhite<-70C06-Jun-18Abbott Architect130 U/LASTAbbott Architect45 U/LALT$75.00K75.81
DLS16-13616-K2NASHCanadaK2 EDTA Plasma1.0010.00$150.0057 YFWhite<-70C10-Jul-18Clinical DiagnosisNASHInitial Date of Disease Diagnosis30-Mar-18Ever Developed JaundiceNo$150.00Liver BiopsyYes | 2-Jun-2017Stage 2 Fibrosis, No Steatosis, +1 Lobular inflammation, No ballooningCirrhosisYes | 30-Mar-2016 Reversal of AST to ALT ratio, Fibroscan, Splenomegaly on ultrasound, VaricesComorbiditiesHypertension, Hypothyroidism, Dyslipidemia, Diabetes, type 2, Portal hypertension / VaricesCurrent Prescription MedicationsDexilant, Nadolol, Invokana, Synthroid, Atorvastatin, Metformin, Jenta Dueto, Candesartan, Vitamin DAll Known Test Results Performed in Previous Six monthsALT: 27 U/L | AST: 43 U/L | GGT: 29 U/L | Bilirubin (direct): 3 umol/L | Bilirubin (total): 17 umol/L | 8-Jun-2018
DLS16-13616-SNASHCanadaSerum1.008.00$150.0057 YFWhite<-70C10-Jul-18Clinical DiagnosisNASHInitial Date of Disease Diagnosis30-Mar-18Ever Developed JaundiceNo$150.00Liver BiopsyYes | 2-Jun-2017Stage 2 Fibrosis, No Steatosis, +1 Lobular inflammation, No ballooningCirrhosisYes | 30-Mar-2016 Reversal of AST to ALT ratio, Fibroscan, Splenomegaly on ultrasound, VaricesComorbiditiesHypertension, Hypothyroidism, Dyslipidemia, Diabetes, type 2, Portal hypertension / VaricesCurrent Prescription MedicationsDexilant, Nadolol, Invokana, Synthroid, Atorvastatin, Metformin, Jenta Dueto, Candesartan, Vitamin DAll Known Test Results Performed in Previous Six monthsALT: 27 U/L | AST: 43 U/L | GGT: 29 U/L | Bilirubin (direct): 3 umol/L | Bilirubin (total): 17 umol/L | 8-Jun-2018
KH18-33884NASHUSAL. Heparin Plasma2.251.00$75.0059 YMWhite<-70C08-Aug-18Abbott Architect77 U/LALTAbbott Architect92 U/LAST$75.00K75.81
KH18-36416NASHUSAK2 EDTA Plasma1.251.00$75.0088 YMWhite<-70C07-Sep-18Abbott Architect2 mg/dLBilirubin Total$75.00K75.81
KH18-37966NASHUSASerum1.251.00$75.0062 YFWhite<-70C29-Aug-18Abbott Architect56 U/LASTAbbott Architect37 U/LALT$75.00K75.81
KH18-38834NASHUSASerum1.251.00$75.0065 YMWhite<-70C11-Sep-18Abbott Architect1.5 mg/dLBilirubin:TotalAbbott Architect0.7 mg/dLBilirubin:Direct$75.00K75.81
KH18-39541NASHUSAK2 EDTA Plasma2.001.00$75.0063 YFWhite<-70C15-Sep-18Abbott Architect32 U/LALTAbbott Architect29 U/LAST$75.00BMI43.58Height | Weight 167.64 cm | 122.47 kgK75.81
KH18-40892NASHUSAL. Heparin Plasma1.751.00$75.0087 YFWhite<-70C23-Sep-18Abbott Architect1.7 mg/dLBilirubin$75.00K75.81
KH18-42468NASHUSAK2 EDTA Plasma1.501.00$75.0051 YMWhite<-70C09-Oct-18Abbott Architect2 mg/dLBilirubin$75.00K75.81
KH18-42469NASHUSAK2 EDTA Plasma1.001.00$75.0063 YMBlack<-70C08-Oct-18Abbott Architect52 U/LALT$75.00K75.81
KH18-45604NASHUSAL. Heparin Plasma1.501.00$75.0077 YFHispanic<-70C14-Oct-18Abbott Architect50 U/LAST$75.00K75.81
KH18-45605NASHUSAL. Heparin Plasma1.501.00$75.0066 YMHispanic<-70C16-Oct-18Abbott Architect68 U/LAST$75.00K75.81
KH18-46920NASHUSASerum1.251.00$75.0051 YMWhite<-70C10-Oct-18Abbott Architect1.5 mg/dLBilirubin Total$75.00K75.81

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.